Skip to content

Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture

Risk-benefit Analysis of Intrathecal Morphine Administration to Patients Undergoing Surgical Treatment of Proximal Femoral Fracture (Monocentric, Single-blinded, Randomized Clinical Study Compared to Standard Treatment)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05920642
Enrollment
82
Registered
2023-06-27
Start date
2023-09-04
Completion date
2025-07-29
Last updated
2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proximal Femur Fracture

Keywords

proximal femur fracture, morphine administration, pain relief, intrathecal administration, parenteral administration, surgery

Brief summary

The aim of the study is to investigate postoperative pain relief for patients undergoing surgical treatment of proximal femoral fracture using intrathecal administration of morphine.

Detailed description

In this study, the investigators will compare the efficiency of intrathecal morphine administration with the standard of care (parenteral application of analgesics) for pain relief in patients after proximal femoral fracture surgery. The secondary outcome measure will be to determine the frequency of adverse effects of intrathecally administered morphine. The study will be monocentric, randomized, and single-blinded. A total of 50 patients are expected to be enrolled.

Interventions

DRUGIntrathecal morphine administration

Administration of morphine into the spinal canal.

Standard postoperative pain management of analgesics using parenteral route of administration.

Sponsors

University Hospital Ostrava
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The participant will not know which arm of the study he/she has been enrolled into.

Intervention model description

The study subjects will be randomized into two parallel groups.

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* signed informed consent * 60 to 90 years of age * surgical treatment of proximal femur fracture * The American Society of Anesthesiologists (ASA) classification I to III * spinal anesthesia used for the operation

Exclusion criteria

* general anesthesia used for the operation * allergy to opioids * high risk of respiratory depression

Design outcomes

Primary

MeasureTime frameDescription
Pain assessmentEvery 2 hours after the surgery, total of 24 hoursPain intensity will be assessed using the Visual Analogue Scale (VAS10) scale (0-10). The total value of all measured values will be calculated. The maximum value observed during the 24 hours will be also recorded.
Pain assessment during patient positioning24 hoursPain intensity will be assessed using the VAS10 scale (0-10) during the positioning of the patient.
Time to administration of rescue medication24 hoursThe time to administration of rescue medication (analgesics) will be observed in hours.
Total consumption of opioids on Intensive Care Unit24 hoursThe total consumption of opioids on Intensive Care Unit will be measured in the number of administered doses.

Secondary

MeasureTime frameDescription
Hypoventilation - other signs of respiratory insufficiency24 hoursThe observed parameters of hypoventilation will include other signs of respiratory insufficiency. Will be evaluated as 0-no, 1-yes + the need for oxygenotherapy, 2-yes+ the need for antidote or other treatment
Hypotension24 hoursThe observed parameters of hypotension will be as follows: systolic blood pressure (SBP) \< 90 mmHg and/or mean arterial pressure (MAP) \< 60 mmHg and/or decrease of blood pressure (BP) by more than 20-30 % of the initial values. Evaluation: 0-no, 1-yes, without administration of noradrenaline, 2-yes, with noradrenaline administration.
Bradycardia24 hoursThe observed parameters of bradycardia will be as follows: heart rate (HR) \< 50/min. Evaluation: 0-no, 1-yes + administration of atropine or ephedrine, 2-yes+ administration of atropine repeatedly or other treatment.
Hypoventilation - bradypnea24 hoursThe observed parameters of hypoventilation include bradypnea = respiratory rate (RR)\<10/min
Effect of antiemetics24 hoursThe effect of antiemetics will be observed. Evaluation: 0-not administered, 1-administered, 2-no effect
Pruritus24 hoursThe presence and condition of pruritus will be observed. Evaluation: 0-no, 1-yes, no scratching, 2-moderate, need of scratching, 3-strong, need of treatment.
Effect of pruritus treatment24 hoursThe effect of pruritus treatment will be observed. Evaluation: 0-no medication administered, 1-administered, 2-no effect
Postoperative nausea and vomiting24 hoursThe incidence of postoperative and vomiting will be observed. Evaluation: 0-no, 1-nausea, 2-vomiting
Hypoventilation - presence of hypopnea (TV < 4)24 hoursThe observed parameters of hypoventilation will include hypopnea = Tidal Volume (TV) \< 4 ml/min. It is a physiological parameter that fluctuates depending on the load in the range of 6-180 liters/min.
Hypoventilation - SpO224 hoursThe observed parameters of hypoventilation will include inability to maintain oxygen saturation (SpO2) above 90 % without the need for oxygenotherapy.
Hypoventilation - presence of hypoxemia (paO2) (below 10 kPa)24 hoursThe observed parameters of hypoventilation will include hypoxemia according to the analysis of blood gasses. Hypoxemia is diagnosed when the partial pressure of oxygen in the arterial blood (paO2) falls below 10 kiloPascals (kPa).

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026